MJA
MJA InSight
MJA Careers
Letters

Bisphosphonate-induced osteonecrosis of the jaw requires early detection and intervention

Simon D J Gibbs, John O'Grady, John F Seymour and H Miles Prince
Med J Aust 2005; 183 (10): 549-550.

Simon D J Gibbs,* John O'Grady, John F Seymour, H Miles Prince§

Simon D J Gibbs, Haematology Registrar
John O'Grady
John F Seymour, Haematoncologist
H Miles Prince, Head
Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne, VIC 8006.
Article References: 
Reference Text: 
Carter G, Goss AN, Doecke C. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 2005; 182: 413-415. <eMJA full text>
Reference Order: 
1
PubMed ID: 
15850439
Reference Text: 
Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003; 61: 1115-1117.
Reference Order: 
2
PubMed ID: 
12966493
Reference Text: 
Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates [letter]. N Engl J Med 2005; 353: 99-102.
Reference Order: 
3
PubMed ID: 
16000365
Reference Text: 
McCloskey EV, Dunn JA, Kanis JA, et al. Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma. Br J Haematol 2001; 113: 1035-1043.
Reference Order: 
4
PubMed ID: 
11442499

The full contents of this page are only available to subscribers.